NANOBIOTIX closes global offering, raises $100 million

Go back to NANOBIOTIX closes global offering, raises $100 million

NANOBIOTIX Announces Closing of Global Offering

May 26, 2026 4:44 PM EDT

PARIS and CAMBRIDGE, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO NASDAQ: NBTX Nanobiotix or the Company), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announces the closing today (the Closing) of its global offering (the Global Offering), including in respect of the earlier total exercise by the underwriters of their option (the Option) to purchase additional new ordinary shares in the form of additional American Depositary Shares (the Additional ADSs).

... More